Attorneys for Wyeth Pharmaceuticals are requesting a rehearing of a Nevada Supreme Court opinion that upheld an $80.7 million award to three women who allegedly contracted breast cancer after taking a hormone drug.
Attorneys for Wyeth Pharmaceuticals are requesting a rehearing of a Nevada Supreme Court opinion that upheld an $80.7 million award to three women who allegedly contracted breast cancer after taking a hormone drug.